featured
Dr. Warren Heymann on a String of (Clinical) Pearls About Drug-Induced Linear IgA Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Pereira AR, Moura LH, Pinheiro JR, et al. Vancomycin-associated linear IgA disease mimicking toxic epidermal necrolysis. An Bras Dermatol. 2016;91(5 suppl 1):35-38.
- Fortuna G, Salas-Alanis JC, Guidetti E, Marinkovich MP. A critical reappraisal of the current data on drug-induced linear immunoglobulin A bullous dermatosis: a real and separate nosological entity? J Am Acad Dermatol. 2012;66(6):988-984.
- Prieto-Barrios M, Velasco-Tamariz V, Tous-Romero F, et al. Linear immunoglobulin A dermatosis mimicking toxic epidermal necrolysis: a case report of etanercept treatment. Br J Dermatol. 2018;178(3):786-789.
- Blatazard T, Dhaille F, Duvert-Lehembre S, et al. Trimethoprim-sulfamethoxazole-induced linear IgA bullous disease presenting as toxic epidermal necrolysis. Dermatol Online J. 2017;23(8):15.
- Nguyen J, Koshelev MV, Gill BJ, et al. A toxic epidermal necrolysis-like presentation of linear IgA bullous dermatosis treated with dapsone. Dermatol Online J. 2017;23(8):6.
- Fulton E, Jan F, Zimarowski MJ. Flame figures in linear IgA bullous dermatosis: a novel histopathologic finding. Dermatol Online J. 2017;23(11):17.
- Yamagami J, Nakamura Y, Nagao K, et al. Vancomycin mediates IgA autoreactivity in drug-indcued linear IgA bullous dermatosis. J Invest Dermatol. 2018;138(7):1473-1480.